NC
Neurocompute
AI-powered research intelligence
 Partner With Us →
Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 40,029 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

Explore Platform → See latest papers
40,029 Papers indexed
1,440 Papers AI scored
40,029 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.
LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
LATEST PEDIATRIC CANCER PAPERS

Database feed

Last ingest 2026-11-04 10:15 AM
1 Drug development for childhood cancers - Authors' reply. The Lancet. Child & adolescent health — Nov 04, 2026 2 Drug development for childhood cancers. The Lancet. Child & adolescent health — Nov 04, 2026 3 Drug development for childhood cancers. The Lancet. Child & adolescent health — Nov 04, 2026 4 Drug development for childhood cancers. The Lancet. Child & adolescent health — Nov 04, 2026 5 Complications in Pediatric Cancer Patients With Staphylococcus aureus Bloodstream Infection. Pediatrics — Nov 04, 2026 6 A systematic overview of the current strategies for managing cancer-related cognitive impairment in children and adolescent cancer survivors. Neuroscience and biobehavioral reviews — Nov 04, 2026 7 Fertility Preservation in Male Children, Adolescents, and Young Adults With Cancer: A Systematic Review and Appraisal of Guidelines. The Journal of urology — Nov 04, 2026 8 Assessing Psychosocial and Supportive Care Needs of Families With Children and Adolescents Diagnosed With Cancer Predisposition Syndromes: Protocol for the KiTDS-Care Mixed Methods Study. JMIR research protocols — Nov 04, 2026
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

40029 results
B
The emerging role of Imatinib in malaria management: a review of evidence and future directions.
PMID 40814068 Published: 2025-08-15 Ingested: 2026-08-02 12:05 AM Tropical diseases, travel medicine and vaccines
AI -
Standard 75.7
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 75.7/100. Study design: 100.0; human relevance: 100.0; therapeutic relevance: 26.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

B
Childhood Cancer Survivorship Globally: A Systematic Review.
PMID 40810994 Published: 2025-08-14 Ingested: 2026-08-02 12:05 AM JAMA oncology
AI -
Standard 75.7
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 75.7/100. Study design: 95.0; human relevance: 75.0; therapeutic relevance: 16.0; sample size: 90.0; recency: 100.0; abstract quality: 100.0.

B
[A multicenter phase 2 trial in children and young adults with newly diagnosed T-ALL: ALL-T11/ T-ALL-211-U from the Japan Children's Cancer Group and the Japan Adult Leukemia Study Group].
PMID 40769928 Published: 2025-01-01 Ingested: 2026-08-02 12:03 AM [Rinsho ketsueki] The Japanese journal of clinical hematology
AI -
Standard 75.7
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 75.7/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 46.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

B
Updated favourable-histology Wilms tumour risk stratification: rationale for future Children's Oncology Group clinical trials.
PMID 40542227 Published: 2025-06-20 Ingested: 2026-08-02 12:04 AM Nature reviews. Urology
AI -
Standard 75.7
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 75.7/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 46.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

B
The effect of an audio-recorded intervention program on the knowledge and self-reported practices of menstruation and hygiene among visually impaired young girls in Rwanda: a mixed method study.
PMID 40361054 Published: 2025-05-13 Ingested: 2026-08-02 12:04 AM BMC public health
AI -
Standard 75.7
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 75.7/100. Study design: 100.0; human relevance: 100.0; therapeutic relevance: 23.5; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

B
Digital Skin Cancer Risk Reduction Interventions for Young Adults: Findings from a Hybrid Type-II Effectiveness-Implementation Trial.
PMID 40131334 Published: 2025-06-03 Ingested: 2026-08-02 12:04 AM Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
AI -
Standard 75.7
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 75.7/100. Study design: 100.0; human relevance: 100.0; therapeutic relevance: 23.5; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

B
Availability and accessibility of cytotoxic medicines in the WHO model list of essential medicines for childhood cancer in low and lower-middle- income countries: a systematic review.
PMID 39891074 Published: 2025-01-31 Ingested: 2026-08-02 12:03 AM BMC cancer
AI -
Standard 75.7
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 75.7/100. Study design: 95.0; human relevance: 75.0; therapeutic relevance: 36.0; sample size: 60.0; recency: 90.0; abstract quality: 100.0.

B
Protocol for a cluster randomised controlled trial to evaluate effectiveness of a self-help group intervention to encourage smoke-free homes in slums of Kochi(Kochi Intervention for tobacco smoke free homes-KIFT).
PMID 39628550 Published: 2024-10-24 Ingested: 2026-08-02 12:02 AM F1000Research
AI -
Standard 75.7
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 75.7/100. Study design: 100.0; human relevance: 100.0; therapeutic relevance: 23.5; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

B
INteractive survivorship program to improve health care REsources [INSPIRE]: A study protocol testing a digital intervention with stepped care telehealth to improve outcomes for adolescent and young adult survivors.
PMID 39561920 Published: 2024-11-17 Ingested: 2026-08-02 12:02 AM Contemporary clinical trials
AI -
Standard 75.7
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 75.7/100. Study design: 100.0; human relevance: 100.0; therapeutic relevance: 23.5; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

B
Educational outcomes school year nine in children treated for acute lymphoblastic leukemia: A nationwide registry-based study from Sweden.
PMID 39425561 Published: 2024-10-19 Ingested: 2026-08-02 12:02 AM International journal of cancer
AI -
Standard 75.7
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 75.7/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 76.0; sample size: 80.0; recency: 90.0; abstract quality: 100.0.

B
Long-Acting Injectable Antipsychotic Medication Use in Youth: A Systematic Review of the Literature Along with MedWatch Safety Data and Prescriber Attitudes.
PMID 39328042 Published: 2024-09-27 Ingested: 2026-08-02 12:02 AM Journal of child and adolescent psychopharmacology
AI -
Standard 75.7
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 75.7/100. Study design: 95.0; human relevance: 75.0; therapeutic relevance: 36.0; sample size: 60.0; recency: 90.0; abstract quality: 100.0.

Previous
Page 364 of 3336
Next
Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.
Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic